OBJECTIVES: Admitting cancer patients to the ICU is associated with clinical and economic impacts. Therefore, the predictability if a cancer patient will benefit from ICU admission is essential. In this study, we aimed to evaluate the ability of health-related quality of life (QoL) prior to ICU admission measured using the EQ-5D-3L, to predict mortality in critically ill cancer patients. METHODS: This was a prospective cohort study of critically ill adult cancer patients in which caregivers were asked a set of questions, utilizing the EQ-5D-3L, to determine patients' QoL prior to ICU admission. The qualitative responses to the EQ-5D-3L were used to calculate the health utility summary measures using the time-trade-off value set for the UK population. To evaluate the predictive value of QoL prior to ICU admission, a receiver operator characteristic (ROC) curve was constructed and the area under the ROC (AUROC) was determined. The cutoff value of the utility score and the predictive values, sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) were calculated. A significance criterion of p<¼0.05 was used. RESULTS: The study included 140 critically ill cancer patients. Baseline QoL was associated with increased mortality (Odds ratio: 3.69; CI: 1.66-8.19; p ¼0.0014). The AUROC for mortality and utility scores prior to ICU admission was 0.6726 (CI,. The utility score of 0.2 was identified as the cut-off point that best predicts overall mortality with a sensitivity of 0.72, specificity of 0.64, PPV of 0.76, and NPV of 0.58. CONCLUSIONS: The quality of life prior to ICU admission, assessed utilizing the EQ-5D-LR, was a identified as a predictor of mortality in cancer patients treated in the ICU.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.